Modulation of tight junction proteins in the perineurium for regional pain control

Annals of the New York Academy of Sciences

Volumn 1257, Issue 1, 2012, Pages 199-206

  Hackel, D ^a,b   Brack, A ^a   Fromm, M ^b   Rittner, H L ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Analgesia; Claudin; Metalloproteinase; Opioid receptors; Opioids; Perineurium; Tight junction proteins

Indexed keywords

ANALGESIC AGENT; CLAUDIN 1; CLAUDIN 5; GELATINASE; GLUCOCORTICOID; HYPERTONIC SOLUTION; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; OCCLUDIN; PROTEIN ZO1; STROMELYSIN;

ANALGESIA; ARTICLE; BLOOD NERVE BARRIER; HUMAN; NERVE CRUSH INJURY; NERVE INJURY; NONHUMAN; PAIN THRESHOLD; PATHOPHYSIOLOGY; PERINEURIUM; PROTEIN FOLDING; TIGHT JUNCTION;

EID: 84861982206     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2012.06499.x     Document Type: Article

References (37)

1. Mizisin, A.P. & A. Weerasuriya. 2011. Homeostatic regulation of the endoneurial microenvironment during development, aging and in response to trauma, disease and toxic insult. Acta Neuropathol. 121: 291-312.
2. Binshtok, A.M., B.P. Bean & C.J. Woolf. 2007. Inhibition of nociceptors by TRPV1-mediated entry of impermeant sodium channel blockers. Nature 449: 607-610.
3. Stein, C., M. Schäfer & H. Machelska. 2003. Attacking pain at its source: new perspectives on opioids. Nat. Med. 9: 1003-1008.
4. Rittner, H.L. & A. Brack. 2007. Leukocytes as mediators of pain and analgesia. Curr. Rheumatol. Rep. 9: 503-510.
5. Antonijevic, I., S.A. Mousa, M. Schäfer & C. Stein. 1995. Perineurial defect and peripheral opioid analgesia in inflammation. J. Neurosci. 15: 165-172.
6. Labuz, D. et al. 2009. Immune cell-derived opioids protect against neuropathic pain in mice. J. Clin. Invest. 119: 278-286.
7. Kieffer, B.L. & C.J. Evans. 2009. Opioid receptors: from binding sites to visible molecules in vivo. Neuropharmacology 56(Suppl 1): 205-212.
8. Zöllner, C. & C. Stein. 2007. Opioids. In Handbook of Experimental Pharmacology. Vol. 177. C. Stein, Ed.: 31-63. Springer-Verlag GmbH. Heidelberg.
9. Stein, C. & C. Zöllner. 2009. Opioids and sensory nerves. In Handbook of Experimental Pharmacology. Vol. 194. B.J. Canning, D. Spina, Eds.: 495-518. Springer-Verlag GmbH. Heidelberg.
10. Simons, E.J., E. Bellas, M.W. Lawlor & D.S. Kohane. 2009. Effect of chemical permeation enhancers on nerve blockade. Mol. Pharm. 6: 265-273.
11. Wenk, H.N., J.-D. Brederson & C.N. Honda. 2006. Morphine directly inhibits nociceptors in inflamed skin. J. Neurophysiol. 95: 2083-2097.
12. Likar, R. et al. 2001. Efficacy of peripheral morphine analgesia in inflamed, noninflamed and perineural tissue of dental surgery patients. J. Pain Symptom Manage. 21: 330-337.
13. Rittner, H.L. et al. 2009. Antinociception by neutrophil-derived opioid peptides in noninflamed tissue-role of hypertonicity and the perineurium. Brain Behav. Immun. 23: 548-557.
14. Capra, N.F. & J.Y. Ro. 2004. Human and animal experimental models of acute and chronic muscle pain: intramuscular algesic injection. Pain 110: 3-7.
15. Rittner, H.L., S. Amasheh, R. Moshourab, et al. 2012. Modulation of tight junction proteins in the perineurium to facilitate peripheral opioid analgesia. Anesthesiology. In press.
16. Piña-Oviedo, S. & C. Ortiz-Hidalgo. 2008. The normal and neoplastic perineurium: a review. Adv. Anat. Pathol. 15: 147-164.
17. Hirakawa, H., S. Okajima, T. Nagaoka, et al. 2003. Loss and recovery of the blood-nerve barrier in the rat sciatic nerve after crush injury are associated with expression of intercellular junctional proteins. Exp. Cell Res. 284: 194-208.
18. Pummi, K.P., A.M. Heape, R.A. Grénman, et al. 2004. Tight junction proteins ZO-1, occludin, and claudins in developing and adult human perineurium. J. Histochem. Cytochem. 52: 1037-1046.
19. Shimizu, F. et al. 2011. Peripheral nerve pericytes modify the blood-nerve barrier function and tight junctional molecules through the secretion of various soluble factors. J. Cell. Physiol. 226: 255-266.
20. Guillemot, L., S. Paschoud, P. Pulimeno, et al. 2008. The cytoplasmic plaque of tight junctions: a scaffolding and signalling center. Biochimica et biophysica acta 1778: 601-613.
21. Shen, L., C.R. Weber, D.R. Raleigh, et al. 2011. Tight junction pore and leak pathways: a dynamic duo. Ann. Rev. Physiol. 73: 283-309.
22. Nitta, T. et al. 2003. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J. Cell Biol. 161: 653-660.
23. Vorbrodt, A.W. & D.H. Dobrogowska. 2004. Molecular anatomy of interendothelial junctions in human blood-brain barrier microvessels. Folia histochemica et cytobiologica/Polish Academy of Sciences, Polish Histochemical and Cytochemical Society 42: 67-75.
24. Ohtsuki, S. et al. 2007. Exogenous expression of claudin-5 induces barrier properties in cultured rat brain capillary endothelial cells. J. Cell. Physiol. 210: 81-86.
25. Dobrogowska, D.H. & A.W. Vorbrodt. 2004. Immunogold localization of tight junctional proteins in normal and osmotically-affected rat blood-brain barrier. J. Mol. Histol. 35: 529-539.
26. Kashiwamura, Y. et al. 2011. Hydrocortisone enhances the function of the blood-nerve barrier through the up-regulation of claudin-5. Neurochem. Res. 36: 849-855.
27. Furuse, M. et al. 2002. Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice. J. Cell Biol. 156: 1099-1111.
28. Tsukita, S. & M. Furuse. 2002. Claudin-based barrier in simple and stratified cellular sheets. Curr. Opin. Cell Biol. 14: 531-536.
29. Tserentsoodol, N., B.C. Shin, H. Koyama, et al. 1999. Immunolocalization of tight junction proteins, occludin and ZO-1, and glucose transporter GLUT1 in the cells of the blood-nerve barrier. Arch. Histol. Cytol. 62: 459-469.
30. Weerasuriya, A., S.I. Rapoport & R.E. Taylor. 1979. Modification of permeability of frog perineurium to [14C]-sucrose by stretch and hypertonicity. Brain Res. 173: 503-512.
31. Terry, S., M. Nie, K. Matter & M.S. Balda. 2010. Rho signaling and tight junction functions. Physiology (Bethesda) 25: 16-26.
32. Bojarski, C. et al. 2004. The specific fates of tight junction proteins in apoptotic epithelial cells. J. Cell Sci. 117: 2097-2107.
33. Gorodeski, G.I. 2007. Estrogen decrease in tight junctional resistance involves matrix-metalloproteinase-7-mediated remodeling of occludin. Endocrinology 148: 218-231.
34. Schubert-unkmeir, A. et al. 2010. Neisseria meningitidis induces brain microvascular endothelial cell detachment from the matrix and cleavage of occludin: a role for MMP-8. PLoS Pathog. 6: e1000874.
35. La Fleur, M., J.L. Underwood, D.A. Rappolee & Z. Werb. 1996. Basement membrane and repair of injury to peripheral nerve: defining a potential role for macrophages, matrix metalloproteinases, and tissue inhibitor of metalloproteinases-1. J. Exp. Med. 184: 2311-2326.
36. Chen, W. et al. 2009. Matrix metalloproteinases inhibition provides neuroprotection against hypoxia-ischemia in the developing brain. J. Neurochem. 111: 726-736.
37. Yang, Y., E.Y. Estrada, J.F. Thompson, et al. 2007. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J. Cereb. Blood Flow Metab. 27: 697-709.